AGN-229666

· Allergan

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for AGN-229666, covering 2014-02-04 to 2016-03-07. Get the full timeline:

Most recent: Clinical Trial Update: AGN-229666 Ophthalmic Solution in Japanese Patients With Allergic Conjunctivitis [Phase 3]